Oxford Immunotec Global PLC (NASDAQ:OXFD) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Herm Rosenman Other companies: Natera, Inc. (Director · Since at least Sep 14, 2018); VIVUS Inc (Director · Feb 20, 2020 – Feb 20, 2020 · Past); Constellation Alpha Capital Corp (Director · Aug 29, 2019 – Jun 1, 2023 · Past) | Director · Jun 18, 2019 – Mar 8, 2021 · Past |
| James R. Tobin Other companies: Lyra Therapeutics, Inc. (Lead Independent Director · Since at least Mar 4, 2022); TransMedics Group, Inc. (Director · Since at least Feb 9, 2021); Globus Medical, Inc. (Director · Since at least Jan 14, 2021) | Director · Mar 8, 2021 – Mar 8, 2021 · Past |
| Ronald Andrews Other companies: Plus Therapeutics, Inc. (Director · Since at least Mar 20, 2026); Precipio, Inc. (Director · Since at least Mar 1, 2021); Insight Molecular Diagnostics Inc. (Former CEO, Director · Jul 1, 2019 – Dec 1, 2022 · Past) | Director · Jun 18, 2019 – Mar 8, 2021 · Past |
| Andrew Scott Walton | Director · Nov 4, 2015 – Mar 8, 2021 · Past |
| Jeff R Schroeder | Chief Commercial Officer · Nov 21, 2013 – May 8, 2017 · Past |
| Patricia Randall | Director · Nov 21, 2013 – Mar 8, 2021 · Past |
| Richard M Altieri | Chief Financial Officer · Nov 21, 2013 – Jan 1, 2019 · Past |